Publications



Developments of mass spectrometry-based technologies for effective drug development linked with clinical proteomes.
Drug Metab Pharmacokinet 2016 Feb 17;31(1):3-11. Epub 2015 Dec 17.
Biosys Technologies, Inc., Meguro-ku, Tokyo, Japan; Department of Thoracic and Thyroid Surgery, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan; Center of Excellence in Biological and Medical Mass Spectrometry, Lund University, BMC, Lund, Sweden.

An improvement on mass spectrometry-based epigenetic analysis of large histone-derived peptides by using the Ionization Variable Unit interface.
Anal Biochem 2015 Oct 5;486:14-6. Epub 2015 Jun 5.
Laboratory for Systems Biology and Medicine, Research Center for Advanced Science and Technology, University of Tokyo, Meguro-Ku, Tokyo 153-8904, Japan. Electronic address:

Clinical initiatives linking Japanese and Swedish healthcare resources on cancer studies utilizing Biobank Repositories.
Clin Transl Med 2014 Dec 22;3(1):61. Epub 2014 Nov 22.
First Department of Surgery, Tokyo Medical University, 6-7-1 Nishishinjuku Shinjuku-ku, Tokyo, 160-0023 Japan ; Clinical Protein Science & Imaging, Biomedical Center, Dept. of Biomedical Engineering, Lund University, BMC D13, 221 84 Lund, Sweden ; Center of Excellence in Biological and Medical mass spectrometry (CEBMMS), 221 84 Lund, Sweden.



Periostin, discovered by nano-flow liquid chromatography and mass spectrometry, is a novel marker of diabetic retinopathy.
Biochem Biophys Res Commun 2010 Aug 21;399(2):221-6. Epub 2010 Jul 21.
Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Showa University School of Medicine, Tokyo, Japan.

Purification of phosphoproteins by immobilized metal affinity chromatography and its application to phosphoproteome analysis.
FEBS J 2007 Mar;274(6):1576-87
Division of Cellular Proteomics (BML), Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-6639, Japan.

OF